Skip to content

Anodal and Cathodal Transcranial Direct Current Stimulation in Stroke Recovery

Effect of Anodal Versus Cathodal Transcranial Direct Current Stimulation on Stroke Recovery: a Pilot Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01601392
Acronym
tDCS
Enrollment
40
Registered
2012-05-18
Start date
2011-01-31
Completion date
2012-06-30
Last updated
2012-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Ischemic stroke, direct current stimulation, motor threshold, National institutes of Health Stroke Scale, Barthel index scale, Measurement of motor power improvement

Brief summary

The purpose of this study will to compare the long-term effect of anodal versus cathodal transcranial direct current stimulation (tDCS) on motor recovery in subacute stroke patients. Forty patients with subacute ischemic stroke will randomly assigned to one of three groups: Anodal, Cathodal and Sham. Each group will receive tDCS at an intensity of 2mA for 25 minutes daily for 6 consecutive days over the affected (Anodal, Sham) or unaffected (Cathodal) motor cortex. Patients will be assessed with National Institutes of Health Stroke Scale (NIHSS), the Barthel index (BI) and the Medical Research Council (MRC) muscle strength scale at baseline, after end of the 6th tDCS session, and then 1, 2 and 3 months later. Motor cortical excitability will be measured at baseline and after the 6th session in both hemispheres.

Interventions

The anodal group will receive tDCS for 25 minutes at 2mA daily for 6 consecutive days on the affected hemisphere.

PROCEDUREtranscranial direct current stimulation (Cathodal)

The Cathodal group will receive tDCS for 25 minutes at 2mA daily for 6 consecutive days on the unaffected hemisphere.

The sham group will receive sham tDCS for 25 minutes daily for 6 consecutive days on the affected hemisphere.

Sponsors

Dina Hatem Elhammady
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* acute hemiparesis with single thromboembolic non-hemorrhagic infarction documented by magnetic resonance imaging (MRI) * Accept to participate in the study

Exclusion criteria

* extensive infarction (taking all territories of middle cerebral artery) * severe flaccid hemiplegia * head injury * Any other neurological disease other than stroke * previous administration of tranquilizer * patients who are unable to give informed consent because of severe aphasia, or cognitive deficit. * Patients with no motor evoked response recorded from First Dorsal Interosseus (FDI) muscle of the affected hand

Design outcomes

Primary

MeasureTime frameDescription
Motor power improvement3 Monthsimprovement in the motor power of paretic patient as measured in one proximal and one distal muscle group testing in upper (shoulder abduction + hand grip) and lower limbs ( hip flexion + toes dorsiflexion).

Secondary

MeasureTime frameDescription
Motor cortical excitability1 MonthThe difference in the motor cortical excitability (RMT, AMT) before and after tDCS

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026